278 related articles for article (PubMed ID: 15104249)
21. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
22. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia.
Chang LC; Tsao LT; Chang CS; Chen CJ; Huang LJ; Kuo SC; Lin RH; Wang JP
Biochem Pharmacol; 2008 Aug; 76(4):507-19. PubMed ID: 18586011
[TBL] [Abstract][Full Text] [Related]
24. Interaction of inflammatory and anti-inflammatory responses in microglia by Staphylococcus aureus-derived lipoteichoic acid.
Huang BR; Tsai CF; Lin HY; Tseng WP; Huang SS; Wu CR; Lin C; Yeh WL; Lu DY
Toxicol Appl Pharmacol; 2013 May; 269(1):43-50. PubMed ID: 23500011
[TBL] [Abstract][Full Text] [Related]
25. Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β.
Yamauchi Y; Okuyama T; Ishii T; Okumura T; Ikeya Y; Nishizawa M
J Nat Med; 2019 Mar; 73(2):353-368. PubMed ID: 30467676
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2-hydroxyphenyl)but-3-en-2-one in RAW 264.7 macrophages.
Tsao LT; Tsai PS; Lin RH; Huang LJ; Kuo SC; Wang JP
Biochem Pharmacol; 2005 Aug; 70(4):618-26. PubMed ID: 15998510
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.
Liu X; Jana M; Dasgupta S; Koka S; He J; Wood C; Pahan K
J Biol Chem; 2002 Oct; 277(42):39312-9. PubMed ID: 12167619
[TBL] [Abstract][Full Text] [Related]
28. Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition.
Tsi CJ; Chao Y; Chen CW; Lin WW
Mol Pharmacol; 2002 Jul; 62(1):90-101. PubMed ID: 12065759
[TBL] [Abstract][Full Text] [Related]
29. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.
Lee AK; Sung SH; Kim YC; Kim SG
Br J Pharmacol; 2003 May; 139(1):11-20. PubMed ID: 12746218
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
33. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha.
Wadsworth TL; McDonald TL; Koop DR
Biochem Pharmacol; 2001 Oct; 62(7):963-74. PubMed ID: 11543732
[TBL] [Abstract][Full Text] [Related]
34. Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophages.
Yeh JL; Hsu JH; Hong YS; Wu JR; Liang JC; Wu BN; Chen IJ; Liou SF
Int J Immunopathol Pharmacol; 2011; 24(2):345-56. PubMed ID: 21658309
[TBL] [Abstract][Full Text] [Related]
35. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity.
Zheng LT; Ock J; Kwon BM; Suk K
Int Immunopharmacol; 2008 Mar; 8(3):484-94. PubMed ID: 18279803
[TBL] [Abstract][Full Text] [Related]
36. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells.
Shu Z; Yang B; Zhao H; Xu B; Jiao W; Wang Q; Wang Z; Kuang H
Int Immunopharmacol; 2014 Apr; 19(2):275-82. PubMed ID: 24462494
[TBL] [Abstract][Full Text] [Related]
37. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE
Lee WS; Shin JS; Jang DS; Lee KT
Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413
[TBL] [Abstract][Full Text] [Related]
38. Fructose-1,6-bisphosphate attenuates induction of nitric oxide synthase in microglia stimulated with lipopolysaccharide.
Kim YC; Park TY; Baik E; Lee SH
Life Sci; 2012 Feb; 90(9-10):365-72. PubMed ID: 22227475
[TBL] [Abstract][Full Text] [Related]
39. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases.
Park HY; Kim GY; Choi YH
Int J Mol Med; 2012 Jul; 30(1):204-10. PubMed ID: 22552813
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G
Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
